Acute otitis externa, noninfective

H8_EXT_NONINF

otitis externa: Inflammation of the anatomical structures of the outer ear and ear canal secondary to an infectious process. Bacterial etiology is most common, but fungal infection is also possible. Symptoms include erythema, edema, and pain.

Suggest a new description

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 H60.5
  • Cause of death: ICD-10 H60.5

2 out of 7 registries used, show all original rules.

600

4. Check minimum number of events

None

600

5. Include endpoints

None

600

6. Filter based on genotype QC (FinnGen only)

600

Control definitions (FinnGen only)

Control exclude
H8_EXTERNAL

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
H60
Name in latin
Otitis externa acuta non infectiosa

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 4704 2439 2237
Only index persons 4262 2271 1991
Unadjusted period prevalence (%)
Whole population 0.07 0.07 0.06
Only index persons 0.08 0.08 0.08
Median age at first event (years)
Whole population 45.42 45.65 45.04
Only index persons 44.12 44.57 43.62

-FinnGen-

Key figures

All Female Male
Number of individuals 600 349 251
Unadjusted period prevalence (%) 0.12 0.12 0.11
Median age at first event (years) 48.80 48.54 49.16

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
538
Matched controls
5378
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H60.5
ICD-10 Finland
Acute otitis externa, noninfective
+∞
323.0
538
10
H60.9
ICD-10 Finland
Otitis externa, unspecified
18.5
94.8
153
113
H60.3
ICD-10 Finland
Other infective otitis externa
92.7
90.8
99
13
H60.8
ICD-10 Finland
Other otitis externa
37.1
66.4
85
27
S02CA02
ATC
flumetasone and antiinfectives; otic
9.6
47.6
103
130
S03CA04
ATC
hydrocortisone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)
13.0
41.4
75
66
UDC00
NOMESCO Finland
Ear microscopy
5.8
36.1
112
234
S03CA01
ATC
dexamethasone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)
14.6
34.6
59
45
H66.0
ICD-10 Finland
Acute suppurative otitis media
6.1
28.1
81
152
Z01.1
ICD-10 Finland
Examination of ears and hearing
3.9
27.9
128
394
H70
ICPC
Otitis externa
15.2
24.8
41
29
J01MA02
ATC
ciprofloxacin; systemic
2.6
24.2
255
1371
H72.0
ICD-10 Finland
Central perforation of tympanic membrane
12.2
24.1
44
39
J01DA01
ATC
[U] cefalexin; systemic
2.5
21.5
384
2676
H90.6
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, bilateral
12.3
21.1
38
33
H60
ICD-10 Finland
Otitis externa
6.7
18.5
48
78
H13
ICPC
Plugged feeling ear
2.8
16.5
123
520
H60.1
ICD-10 Finland
Cellulitis of external ear
14.9
16.5
27
19
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
2.8
15.8
117
493
Z97.4
ICD-10 Finland
Presence of external hearing-aid
5.0
15.5
51
111
H04
ICPC
Ear discharge
7.3
15.4
37
54
H29
ICPC
Ear symptom/complaint other
3.4
15.2
77
250
H01
ICPC
Ear pain/earache
3.2
15.0
87
310
H71
ICD-10 Finland
Cholesteatoma of middle ear
11.8
14.9
27
24
H61.2
ICD-10 Finland
Impacted cerumen
4.6
14.9
52
121
H65.0
ICD-10 Finland
Acute serous otitis media
10.5
14.6
28
28
H66.3
ICD-10 Finland
Other chronic suppurative otitis media
37.1
14.5
18
5
H65.3
ICD-10 Finland
Chronic mucoid otitis media
7.3
14.3
34
49
H66.9
ICD-10 Finland
Otitis media, unspecified
4.2
13.9
54
140
H66.4
ICD-10 Finland
Suppurative otitis media, unspecified
18.8
13.5
20
11
J01DA09
ATC
[U] cefadroxil; inhalant, oral
2.2
12.9
170
951
H62.0*A46
ICD-10 Finland
Otitis externa in erysipelas
71.6
12.6
14
*
H72.9
ICD-10 Finland
Perforation of tympanic membrane, unspecified
20.6
12.5
18
9
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
3.8
12.0
52
149
H61.8
ICD-10 Finland
Other specified disorders of external ear
19.4
11.6
17
9
H60.0
ICD-10 Finland
Abscess of external ear
35.8
11.3
14
*
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.2
10.9
128
672
S02CA06
ATC
dexamethasone and antiinfectives; otic
18.3
10.8
16
9
D07AB02
ATC
hydrocortisone butyrate; topical
2.0
10.7
166
981
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
2.0
10.5
159
928
DBD20
NOMESCO Finland
Plastic repair of external auditory canal
112.1
10.5
11
*
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
2.2
10.3
111
559
T90
ICPC
Diabetes non-insulin dependent
2.1
9.8
119
634
H92.0
ICD-10 Finland
Otalgia
3.7
9.7
42
121
H65.2
ICD-10 Finland
Chronic serous otitis media
8.3
9.4
20
25
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.8
9.1
196
1288
H74.1
ICD-10 Finland
Adhesive middle ear disease
19.0
9.0
13
7
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.7
8.8
301
2273
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
5.3
8.6
25
49
DCD00
NOMESCO Finland
Myringoplasty
9.7
8.3
16
17
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
3.7
8.2
34
95
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.0
8.2
106
577
H70.1
ICD-10 Finland
Chronic mastoiditis
22.4
8.0
11
5
Z3229
NOMESCO Finland
Other healthcare associate professional
2.7
8.0
57
230
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.1
7.9
98
521
R06.0
ICD-10 Finland
Dyspnoea
1.9
7.8
131
783
S18
ICPC
Laceration/cut
1.7
7.8
219
1544
J01CA04
ATC
amoxicillin; systemic
1.8
7.8
428
3660
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.7
7.8
226
1605
J01DB01
ATC
cefalexin; oral
1.8
7.8
428
3662
J01FA10
ATC
azithromycin; systemic
1.7
7.8
309
2401
103
Kela drug reimbursment
Diabetes, insulin-treated
1.9
7.8
135
818
3853A
ICD-9 Finland
Other disorders of middle ear and mastoid, Cholesteatoma of middle ear and mastoid
45.6
7.7
9
*
3821A
ICD-9 Finland
Suppurative and unspecified otitis media, Chronic tubotympanic suppurative otitis media
45.6
7.7
9
*
D07AC01
ATC
betamethasone; topical
1.7
7.6
185
1247
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.0
7.5
99
538
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.7
7.3
206
1444
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.6
7.3
266
2003
DFF00
NOMESCO Finland
Pure tone audiometry
2.5
7.3
57
245
D07CC01
ATC
betamethasone and antibiotics; topical
2.2
7.2
75
371
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.9
7.1
120
718
SAA01
NOMESCO Finland
Simple examination of mouth
1.7
7.1
362
2980
R07.4
ICD-10 Finland
Chest pain, unspecified
1.8
6.9
139
880
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.7
6.9
214
1537
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.8
6.8
148
958
SAA03
NOMESCO Finland
Extended examination of mouth
1.7
6.7
198
1401
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.5
6.7
50
210
H81
ICPC
Excessive ear wax
2.0
6.7
86
464
TDA90
NOMESCO Finland
Removal wax from ear
6.6
6.7
16
25
E66.01
ICD-10 Finland
Obesity due to excess calories
2.6
6.7
49
202
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.3
6.7
58
264
H65.1
ICD-10 Finland
Other acute nonsuppurative otitis media
8.0
6.6
14
18
DAX08
NOMESCO Finland
Fitting of hearing aid
3.5
6.6
29
86
D07CA01
ATC
hydrocortisone and antibiotics; topical
2.1
6.6
74
378
DC1AD
NOMESCO Finland
Temporalbone CT
8.8
6.6
13
15
I25.2
ICD-10 Finland
Old myocardial infarction
2.8
6.6
40
150
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
3.8
6.6
26
71
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.7
6.5
151
993
K03.18
ICD-10 Finland
Other abrasion of the teeth
7.5
6.4
14
19
A10BA02
ATC
metformin; oral
1.8
6.4
136
870
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.7
6.4
169
1155
K02.1
ICD-10 Finland
Caries of dentine
1.6
6.4
293
2313
C03CA01
ATC
furosemide; systemic
1.7
6.3
141
918
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.9
6.3
91
514
R5120
NOMESCO Finland
Preparation of an aid
4.2
6.3
22
54
DEB30
NOMESCO Finland
Radical mastoidectomy
+∞
6.3
6
*
DBB00
NOMESCO Finland
Excision of lesion of external auditory canal
+∞
6.3
6
*
H73.1
ICD-10 Finland
Chronic myringitis
+∞
6.3
6
*
J02AC01
ATC
fluconazole; systemic
1.6
6.1
207
1511
A46
ICD-10 Finland
Erysipelas
2.0
6.1
74
391

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3007853) Bacteria identified in Skin by Aerobe culture
152
515
3.61
37.39
2.4
1.6
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
106
561
2.08
9.73
1.6
1.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
118
670
1.95
8.86
2.2
2.0
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
213
1470
1.70
8.30
4.1
2.5
u/l
65.0
56.5
0.40
200
1363
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
201
1389
1.67
7.68
2.3
2.0
u/l
214.2
240.4
0.13
193
1308
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
242
1787
1.59
6.92
4.6
3.5
ng/l
68.9
56.7
0.13
174
1218
(3013826) Glucose [Moles/volume] in Serum or Plasma
342
2744
1.57
6.77
5.5
4.5
mmol/l
6.8
6.7
0.36
318
2540
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
41
173
2.47
6.44
2.0
1.9
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
94
558
1.81
6.04
8.3
5.2
mmol/l
1.1
1.0
1.24
89
514
(3020682) Albumin/Creatinine [Ratio] in Urine
199
1441
1.57
6.01
4.1
4.0
mg/mmol
8.4
8.7
0.03
121
896
(40768797) Stomach Pathology biopsy report
103
640
1.74
5.66
1.3
1.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
187
1368
1.53
5.28
3.6
3.2
mg/l
781.3
201.7
0.56
117
866
(3009343) pH of Capillary blood
57
300
1.99
5.27
4.1
3.5
ph
7.4
7.4
—
9
24
(3026493) Urate [Moles/volume] in Serum or Plasma
167
1203
1.54
5.02
2.7
2.6
umol/l
5258.2
7073.6
0.20
144
1044
(40761535) Cells panel - Urine sediment
66
373
1.86
4.96
4.5
3.2
—
—
—
0
0
(3019225) pH of Specimen
73
429
1.80
4.84
6.4
4.2
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
279
2246
1.45
4.79
8.5
6.5
mmol/l
1.2
1.2
0.91
233
1911
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
93
590
1.68
4.72
5.0
4.3
%
31.9
32.0
0.03
63
394
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
106
696
1.64
4.71
1.9
1.8
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
53
284
1.95
4.68
4.2
3.6
mmol/l
1.5
1.9
0.45
43
215
(3019060) Gas panel - Arterial blood
54
294
1.92
4.55
5.3
4.5
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
21
77
2.79
4.39
3.3
2.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
34
158
2.22
4.36
2.1
1.7
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
186
1409
1.46
4.29
3.2
2.8
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
119
821
1.56
4.29
1.8
1.7
nmol/l
1141.5
1191.9
0.28
98
625
(3032080) INR in Blood by Coagulation assay
233
1842
1.43
4.28
8.9
7.9
inr
1.2
1.2
0.16
61
541
(3013707) Erythrocyte sedimentation rate by Westergren method
410
3587
1.45
4.28
5.0
4.0
mm/h
12.0
11.7
0.19
379
3309
(3009508) Creatinine [Moles/volume] in Urine
194
1487
1.45
4.19
3.6
3.1
mmol/l
7.3
7.6
0.39
163
1247
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
418
3678
1.45
4.17
4.5
3.9
pmol/l
14.6
14.7
0.66
379
3335
(3017732) Neutrophils [#/volume] in Blood
57
326
1.83
4.14
5.1
3.0
e9/l
4.7
4.1
1.01
41
253
(3023368) Bacteria identified in Blood by Culture
165
1229
1.47
4.13
4.2
4.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
28
124
2.32
4.03
2.2
1.5
—
—
—
0
0
(3012544) pH of Venous blood
69
422
1.72
4.01
4.2
3.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
49
271
1.88
3.96
1.5
1.4
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
233
1865
1.41
3.91
2.1
1.9
pmol/l
98.9
95.8
0.43
140
951
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
251
2043
1.39
3.79
7.3
5.6
mmol/l
1.2
1.2
0.81
230
1859
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
114
800
1.52
3.79
1.3
1.2
u/ml
2.3
10.7
3.24
56
311
(3026389) Candida sp identified in Specimen by Organism specific culture
16
55
2.96
3.76
1.4
1.3
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
292
2443
1.38
3.71
6.6
5.7
e9/l
1.9
1.9
0.14
267
2187
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
150
1121
1.45
3.64
2.4
2.3
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
54
317
1.77
3.62
1.6
1.5
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
103
714
1.53
3.61
3.8
3.4
mmol/l
0.8
0.8
1.22
95
675
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
128
934
1.47
3.51
1.7
1.7
pmol/l
50000476.1
24081553.6
0.21
106
789
(3013115) Eosinophils [#/volume] in Blood
293
2469
1.36
3.49
6.4
6.1
e9/l
0.2
0.2
0.35
260
2203
(3001604) Monocytes [#/volume] in Blood
283
2372
1.37
3.48
6.2
5.7
e9/l
0.6
0.6
1.93
251
2078
(3047181) Lactate [Moles/volume] in Blood
28
134
2.14
3.39
5.1
6.9
mmol/l
1.7
1.2
1.08
22
118
(3020891) Body temperature
32
162
2.03
3.36
6.8
4.3
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
27
128
2.16
3.35
1.4
1.5
ug/g
213.1
283.5
1.05
12
80
(3006315) Basophils [#/volume] in Blood
283
2385
1.35
3.31
6.2
5.7
e9/l
0.0
0.0
0.50
251
2093
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
21
90
2.38
3.28
8.5
6.7
iu/ml
699.4
141.6
—
5
13
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
58
360
1.68
3.22
5.1
3.5
ng/l
131.4
74.9
1.46
44
327
(3023520) Reticulocytes [#/volume] in Blood
58
360
1.68
3.22
2.8
2.8
e9/l
79.9
72.5
0.62
52
278
(3003327) Ova and parasites identified in Stool by Light microscopy
29
144
2.07
3.21
1.3
1.6
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
238
1961
1.35
3.19
5.7
4.7
g/l
35.3
35.8
0.65
223
1825
(3036481) Cortisol [Moles/volume] in Serum or Plasma
66
427
1.61
3.12
2.0
2.0
nmol/l
338.7
369.7
0.66
58
397
(3042733) HLA Ab [Presence] in Serum
6
8
7.56
3.06
6.8
1.9
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
272
2300
1.33
3.03
6.6
5.9
%
27.1
28.0
0.74
252
2153
(3025941) Bacteria identified in Stool by Culture
45
265
1.75
3.02
1.4
1.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
92
647
1.50
3.02
1.5
1.3
titre
652.5
521.1
0.17
16
141
(3013512) EKG study
174
1375
1.37
3.02
5.6
3.7
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
31
162
1.96
3.00
4.9
4.1
mmol/l
1.3
1.3
0.07
31
157
(40760888) Immunoglobulin light chains.free panel - Serum
22
101
2.22
2.96
3.2
3.8
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
11
35
3.18
2.94
1.8
1.4
%
25.4
29.8
—
5
24
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
113
832
1.44
2.94
1.3
1.3
iu/ml
26.1
35.8
0.34
36
274
(3022313) Gas panel - Capillary blood
40
230
1.79
2.91
4.1
3.6
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
291
2497
1.32
2.88
7.1
6.2
umol/l
10.6
10.9
0.24
279
2371
(3002032) Base excess in Venous blood by calculation
62
405
1.59
2.83
4.5
3.5
mmol/l
2.4
2.0
0.17
48
319
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
11
36
3.09
2.82
1.0
1.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
142
1097
1.39
2.81
5.2
4.6
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
8
18
4.49
2.80
1.0
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
8
18
4.49
2.80
1.0
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
8
18
4.49
2.80
1.0
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
10
31
3.26
2.78
1.1
1.0
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
5
6
8.39
2.75
1.0
1.5
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
184
1486
1.34
2.74
2.5
2.3
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
26
132
2.01
2.74
2.9
3.4
ratio
1.1
1.1
—
6
18
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
13
48
2.75
2.73
1.6
1.5
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
11
37
3.01
2.70
1.0
1.1
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
90
647
1.46
2.65
3.5
2.2
g/l
2.4
2.4
0.63
85
600
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
148
1164
1.36
2.61
2.6
2.0
mg/l
3.0
3.0
0.09
129
995
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
478
4438
1.38
2.58
6.9
5.6
mmol/mol
40.9
39.8
1.69
441
4131
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
407
3690
1.32
2.57
8.9
7.4
u/l
83.5
77.6
0.55
389
3458
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
16
68
2.39
2.57
1.5
1.3
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
261
2231
1.30
2.57
6.3
5.8
%
2.9
2.8
0.10
239
2077
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
12
44
2.76
2.56
1.2
1.3
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
7
16
4.41
2.48
1.1
1.1
miu/ml
1343.9
1343.9
—
7
16
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
15
63
2.42
2.48
1.2
1.4
nmol/l
0.2
0.4
—
10
50
(42870588) Differential panel, method unspecified - Blood
190
1565
1.31
2.43
6.1
5.9
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
80
572
1.46
2.43
8.7
6.7
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
476
4429
1.36
2.43
5.5
4.7
mu/l
1.8
1.9
0.58
440
4051
(3019069) Monocytes/100 leukocytes in Blood
260
2237
1.29
2.39
6.8
6.1
%
8.7
8.5
0.42
241
2103
(3013650) Neutrophils [#/volume] in Blood by Automated count
315
2777
1.28
2.38
9.9
9.2
e9/l
4.1
4.0
0.44
282
2454
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
84
610
1.44
2.36
3.6
2.2
%
22.3
22.6
0.08
74
529
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
19
91
2.12
2.35
2.1
1.2
u/ml
107.0
104.9
—
6
20
(3018010) Neutrophils/100 leukocytes in Blood
263
2274
1.28
2.30
6.5
5.7
%
58.3
57.1
0.90
242
2142
(1761868) Lipid panel - Serum or Plasma
146
1791
0.76
2.27
3.1
2.8
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
55
370
1.54
2.25
2.8
3.0
g/l
66.4
67.2
0.33
48
339
(40768446) Kidney Pathology biopsy report
5
9
5.59
2.21
1.8
1.9
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
55
372
1.53
2.20
2.3
2.4
ml/min/173m2
57.8
67.6
1.03
23
147
(3037467) Urinalysis macro (dipstick) panel - Urine
363
3276
1.27
2.20
5.5
4.2
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
6
14
4.32
2.15
1.0
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
6
14
4.32
2.15
1.0
1.1
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
94
710
1.38
2.12
3.7
2.2
umol/l
13.4
13.2
0.10
88
659
(3002385) Erythrocyte distribution width [Ratio]
378
4104
0.79
2.10
18.2
16.3
%
13.8
13.6
1.31
365
4030
(3022096) Basophils/100 leukocytes in Blood
250
2166
1.26
2.10
6.6
5.8
%
0.7
0.7
0.18
229
2025
(3022145) Colonoscopy Study observation
73
532
1.42
2.03
1.4
1.3
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
19
97
1.99
2.02
1.9
1.3
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
15
70
2.17
2.00
1.1
1.0
u/ml
2.8
4.6
—
9
30
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
21
112
1.91
1.98
1.5
1.3
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
185
1555
1.27
1.98
3.6
3.3
mmol/l
2.3
2.4
1.53
160
1361
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
11
45
2.47
1.94
1.3
1.2
u/l
50.3
52.0
—
6
30
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
19
99
1.95
1.92
1.9
1.2
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
522
4974
1.38
1.92
20.6
15.2
mmol/l
4.0
4.0
0.26
509
4834
(3019550) Sodium [Moles/volume] in Serum or Plasma
521
4963
1.38
1.92
20.8
15.1
mmol/l
139.6
139.7
0.24
509
4830
(3022217) INR in Platelet poor plasma by Coagulation assay
74
547
1.40
1.91
21.1
20.8
inr
1.4
1.2
0.56
17
77
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
14
65
2.18
1.89
1.4
1.4
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
224
1935
1.25
1.89
2.5
2.2
nmol/l
75.0
76.1
0.27
197
1735
(3004809) Band form neutrophils/100 leukocytes in Blood
15
72
2.11
1.87
1.7
3.4
%
1.5
1.0
—
9
59
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
8
28
2.88
1.86
1.4
1.1
u/l
64.8
89.7
—
8
20
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
17
86
2.01
1.86
3.4
4.0
%
58.2
58.3
0.01
17
86
(3021960) Folate [Moles/volume] in Serum or Plasma
131
1064
1.30
1.82
1.5
1.5
nmol/l
20.8
21.2
0.10
108
907
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
7
23
3.07
1.80
1.9
1.6
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
18
95
1.92
1.77
1.6
1.7
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
135
1106
1.28
1.76
1.3
1.2
u/ml
1.0
1.9
0.96
40
308
(3016018) Differential panel - Cerebral spinal fluid
9
36
2.52
1.74
1.0
1.7
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
8
30
2.69
1.73
1.0
1.2
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
5
13
3.87
1.72
1.6
1.0
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
12
55
2.21
1.68
1.6
1.5
%
75.0
61.3
—
6
43
(1002224) Polysomnography panel
11
225
0.48
1.66
1.0
1.1
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
6
19
3.18
1.66
1.2
1.7
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
67
500
1.38
1.65
3.9
2.8
%
2.0
1.8
0.42
61
455
(40768804) Tissue Pathology biopsy report
220
1922
1.23
1.63
2.3
2.0
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
16
84
1.93
1.61
3.3
3.6
e9/l
4.1
4.3
0.14
16
84
(3021788) Differential panel - Synovial fluid
16
84
1.93
1.61
1.5
1.6
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
50
357
1.44
1.58
4.3
4.1
%
0.5
0.5
0.03
11
82
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
129
1066
1.27
1.57
1.6
1.7
mg/l
1.0
1.2
1.16
107
807
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
13
64
2.05
1.55
1.4
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
13
64
2.05
1.55
1.4
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
13
64
2.05
1.55
1.4
1.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
152
1284
1.25
1.53
5.5
3.7
estimate
0.0
0.0
0.69
57
441
(3017181) Myelocytes/100 leukocytes in Blood
54
394
1.41
1.53
4.1
4.1
%
1.1
1.0
0.08
17
122
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
21
123
1.73
1.52
1.4
1.3
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
5
15
3.35
1.52
1.0
1.0
—
4.3
—
0
5
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
156
1323
1.24
1.51
3.9
3.0
ng/l
1200.5
1087.0
0.19
139
1125
(3021440) Promyelocytes/100 leukocytes in Blood
51
369
1.42
1.51
4.2
4.3
%
0.1
0.2
0.78
16
109
(3008401) Mugwort IgE Ab [Units/volume] in Serum
13
65
2.02
1.49
1.1
1.0
u/ml
9.8
0.5
—
6
22
(3005988) Vibrio sp identified in Specimen by Organism specific culture
13
65
2.02
1.49
1.4
1.4
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
510
4882
1.30
1.49
18.4
13.2
mg/l
19.8
23.0
1.62
429
3828
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
491
4687
1.26
1.40
5.3
4.4
mmol/l
6.2
5.9
2.25
448
4278
(3007164) IgA [Mass/volume] in Serum or Plasma
118
978
1.26
1.40
1.5
1.4
g/l
2.5
2.4
0.09
80
597
(3003396) Base excess in Arterial blood by calculation
66
506
1.34
1.40
7.2
7.3
mmol/l
1.9
1.2
0.68
50
411
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
63
814
0.75
1.39
3.0
2.8
ug/l
0.6
0.7
0.53
44
516
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
9
41
2.21
1.37
1.0
1.1
—
—
—
0
0
(3000012) Reticulocyte production index
6
23
2.62
1.37
1.0
1.7
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
6
23
2.62
1.37
1.0
1.9
nmol/l
1.0
1.1
—
6
17
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
17
97
1.77
1.36
1.5
1.2
u/ml
274.5
254.0
—
10
56
(1616796) Gas panel - Central venous blood
16
90
1.80
1.34
7.1
2.5
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
43
310
1.42
1.32
2.7
2.4
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
248
2229
1.19
1.31
4.2
3.9
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
353
3275
1.19
1.29
3.9
3.1
u/l
58.1
46.2
0.73
334
3077
(3017817) Protein [Mass] in Urine collected for unspecified duration
8
34
2.37
1.29
1.0
3.0
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
5
18
2.79
1.28
1.0
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
17
99
1.74
1.28
1.5
1.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
34
236
1.47
1.28
2.5
2.3
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
8
35
2.30
1.27
1.1
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
30
205
1.49
1.22
1.4
1.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
20
124
1.63
1.22
1.3
1.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
6
26
2.32
1.19
1.0
1.3
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
11
57
1.95
1.17
4.6
3.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
25
166
1.53
1.17
4.7
3.6
g/l
0.1
0.2
—
10
63
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
24
158
1.54
1.16
1.2
2.2
g/l
3.2
3.1
0.08
16
128
(3012441) Differential panel - Pleural fluid
8
39
2.07
1.15
1.5
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
12
65
1.86
1.14
1.4
1.4
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
14
80
1.77
1.13
1.2
1.1
u/ml
3.2
1.4
—
7
26
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
10
51
1.98
1.11
1.0
1.1
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
25
168
1.51
1.11
1.2
2.2
g/l
3.8
3.8
0.10
16
126
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
25
168
1.51
1.11
1.2
2.2
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
25
168
1.51
1.11
1.2
2.2
g/l
7.7
7.5
0.16
18
131
(3031040) Bacteria [#/volume] in Urine by Automated count
335
3119
1.17
1.10
5.3
4.3
e6/l
8.6
3302.5
—
5
58
(3044290) Cell count panel - Cerebral spinal fluid
15
89
1.70
1.08
1.0
1.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
52
402
1.32
1.08
4.7
3.5
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
10
52
1.94
1.06
1.5
3.0
%
69.4
56.6
—
5
38
(3000850) Epithelial cells [#/volume] in Urine
113
962
1.22
1.06
3.1
2.5
e6/l
7.8
5.3
0.80
103
853
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
87
721
1.24
1.05
1.9
1.6
—
—
—
0
0
(3003338) MCHC [Mass/volume]
398
4187
0.85
1.05
22.0
17.1
g/l
332.5
332.6
0.09
393
4163
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
5
22
2.28
1.03
5.4
2.0
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
5
22
2.28
1.03
1.2
1.1
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
13
75
1.75
1.03
5.0
3.2
—
3918.1
—
0
7
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
335
3132
1.16
1.01
3.1
3.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
72
587
1.26
1.01
2.7
2.3
ug/g
107.2
133.7
0.63
59
468
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
9
48
1.89
1.01
1.1
1.3
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
7
35
2.01
1.00
1.1
1.1
—
94.4
—
0
5
(21494755) Public health laboratory ask at order entry panel
39
512
0.75
1.00
1.2
1.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
7
135
0.51
0.99
5.1
3.0
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
9
49
1.85
0.99
1.0
1.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
20
132
1.53
0.98
3.1
2.4
ug/min
99.4
42.8
0.61
12
77
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
29
0.00
0.98
0.0
1.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
12
69
1.75
0.97
1.2
1.6
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
68
556
1.25
0.94
2.0
1.5
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
9
52
1.74
0.92
2.4
2.6
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
10
55
1.83
0.92
2.1
1.7
pg
31.7
32.9
—
10
55
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
23
159
1.46
0.92
1.8
2.2
u/l
423.4
3316.3
—
6
61
(4010399)
44
341
1.31
0.92
1.7
1.4
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
39
297
1.33
0.92
1.3
1.3
—
44.3
—
0
15
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
24
168
1.45
0.91
1.5
1.6
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
6
29
2.08
0.89
1.3
1.3
—
—
—
0
0
(4027681)
6
29
2.08
0.89
1.2
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
22
311
0.70
0.89
1.7
1.4
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
8
42
1.92
0.89
1.3
1.8
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
203
1846
1.15
0.88
5.1
3.6
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
177
1594
1.16
0.87
3.3
3.2
u/l
32.2
31.3
0.12
166
1521
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
6
30
2.01
0.87
1.0
1.6
—
275.0
—
0
6
(3038177) Helicobacter pylori Ab [Presence] in Serum
11
64
1.73
0.86
1.1
1.2
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
226
2073
1.14
0.86
3.6
2.7
ug/l
106.0
114.6
0.35
207
1909
(3035637) Corticotropin [Mass/volume] in Plasma
8
44
1.83
0.86
1.3
1.6
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
38
486
0.77
0.83
1.3
1.5
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
32
242
1.34
0.80
1.1
1.0
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
10
58
1.74
0.80
1.5
1.2
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
44
349
1.28
0.80
4.7
4.4
%
0.1
1.1
0.55
12
93
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
12
74
1.63
0.78
1.0
1.1
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
26
0.00
0.78
0.0
2.2
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
42
333
1.28
0.77
2.3
2.2
nmol/l
12.4
13.9
0.65
36
297
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
532
5197
1.21
0.75
12.4
10.1
u/l
27.4
26.1
0.57
512
5024
(3030981) Hyaline casts [#/volume] in Urine by Automated count
33
254
1.32
0.75
3.8
2.6
e6/l
0.1
0.1
0.57
33
244
(3048929) Epstein Barr virus Ab [Presence] in Serum
23
167
1.39
0.74
1.6
1.2
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
7
38
1.85
0.73
1.0
2.8
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
64
537
1.21
0.73
1.6
1.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
5
25
2.01
0.73
1.2
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
5
25
2.01
0.73
1.2
1.8
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
5
25
2.01
0.73
1.2
1.8
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
5
25
2.01
0.73
1.2
1.8
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
45
365
1.25
0.70
1.1
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
14
93
1.52
0.70
2.0
1.5
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
41
329
1.26
0.70
2.5
2.4
—
17.5
—
0
12
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
5
27
1.86
0.68
1.0
1.2
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
5
93
0.53
0.67
1.6
1.5
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
5
93
0.53
0.67
1.6
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
5
95
0.52
0.67
1.6
1.5
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
13
86
1.52
0.66
4.6
1.8
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
58
488
1.21
0.65
1.8
1.8
—
—
—
0
0
(3000991) Gas panel - Venous blood
44
360
1.24
0.65
7.4
7.6
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
5
29
1.73
0.64
1.0
1.8
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
20
147
1.37
0.62
3.2
2.8
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
472
4587
1.14
0.62
15.3
12.2
ml/min/173m2
81.9
82.4
0.21
413
3761
(3009542) Hematocrit [Volume Fraction] of Blood
436
4495
0.89
0.61
15.1
14.1
%
39.6
40.1
0.40
290
3317
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
42
345
1.23
0.60
1.1
1.2
iu/ml
165.4
123.0
0.29
14
146
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
2.6
—
841.5
—
0
20
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
21
0.00
0.60
0.0
1.4
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
8
52
1.55
0.59
1.4
1.3
pmol/l
369.9
362.0
—
8
41
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
37
452
0.81
0.59
1.8
1.7
—
—
—
0
0
(3018418) pH of Serum or Plasma
149
1363
1.12
0.58
5.0
3.8
ph
7.4
7.4
0.80
41
255
(44813793)
6
35
1.72
0.58
1.0
1.0
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
57
486
1.19
0.57
1.7
1.8
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
11
73
1.52
0.56
1.1
1.1
—
—
—
0
0
(4035726)
48
404
1.20
0.56
1.5
1.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
8
122
0.65
0.55
1.1
1.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
55
470
1.19
0.55
3.3
3.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
96
858
1.14
0.54
3.0
2.9
mmol/l
2.4
2.4
0.86
79
748
(3008757) Leukocyte morphology finding [Identifier] in Blood
9
60
1.51
0.54
1.4
3.8
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
97
868
1.14
0.54
4.5
3.5
ng/l
40.7
256.6
3.62
65
653
(3002523) Influenza virus A Ag [Presence] in Specimen
11
74
1.50
0.53
1.1
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
11
74
1.50
0.53
1.1
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
19
143
1.34
0.53
1.1
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
19
143
1.34
0.53
1.1
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
490
4789
1.13
0.52
4.9
4.3
mmol/l
1.4
1.5
1.10
453
4421
(3003694) ABO and Rh group [Type] in Blood
123
1345
0.89
0.52
1.5
1.4
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
9
64
1.41
0.51
3.9
2.8
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
492
4811
1.13
0.51
5.0
4.4
mmol/l
4.6
4.7
1.83
460
4466
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
11
75
1.48
0.51
1.5
1.2
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
9
65
1.39
0.50
3.9
2.8
mmol/l
4.1
4.0
—
9
65
(3035285) Chloride [Moles/volume] in Venous blood
9
65
1.39
0.50
3.9
2.8
mmol/l
105.0
105.9
—
9
65
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
10
67
1.50
0.50
1.0
1.1
g/l
1.7
1.5
—
10
60
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
19
145
1.32
0.49
1.5
2.2
ug/l
275.1
281.6
0.01
19
135
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
500
4897
1.13
0.49
5.3
4.8
mmol/l
2.7
2.8
1.39
460
4512
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
7
109
0.64
0.49
1.4
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
7
109
0.64
0.49
1.4
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
7
109
0.64
0.49
1.4
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
7
109
0.64
0.49
1.4
1.5
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
13
93
1.41
0.48
2.0
3.9
umol/l
33.3
36.0
0.25
13
82
(3011397) Hemoglobin [Presence] in Urine by Test strip
118
1078
1.12
0.48
5.0
3.5
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
11
76
1.46
0.48
1.4
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
7
47
1.50
0.47
2.9
2.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
19
146
1.31
0.47
1.1
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
21
164
1.29
0.47
2.4
2.0
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
69
610
1.15
0.47
1.7
1.7
%
1.6
1.4
1.13
57
538
(1617658) Protocol used for examination of sentinel lymph nodes
7
48
1.46
0.47
1.0
1.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
8
117
0.68
0.46
1.4
1.6
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
7
50
1.40
0.45
2.9
2.6
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
16
121
1.33
0.44
3.3
2.6
u/ml
0.3
0.3
—
10
67
(3035350) Ketones [Presence] in Urine by Test strip
246
2340
1.09
0.44
4.8
3.5
estimate
0.0
0.0
0.00
57
447
(3004616) Nuclear Ab [Presence] in Serum
7
51
1.38
0.44
1.1
1.2
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
126
1163
1.11
0.43
4.4
3.7
%
93.4
92.2
0.20
121
1138
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
5
31
1.62
0.43
1.0
1.1
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
5
32
1.57
0.42
1.0
1.1
—
5.3
—
0
11
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
8
57
1.41
0.42
2.8
1.7
ug/l
15.5
16.1
—
8
57
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
5
33
1.52
0.41
1.0
1.1
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
5
33
1.52
0.41
2.0
1.3
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
15
0.00
0.41
0.0
1.0
—
129.3
—
0
15
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
0
15
0.00
0.41
0.0
1.0
—
106.4
—
0
10
(4015189)
0
15
0.00
0.41
0.0
2.4
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
0
15
0.00
0.41
0.0
1.0
—
96.9
—
0
10
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
3.0
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
(3026782) Osmolality of Urine
98
898
1.11
0.39
3.5
2.6
mosm/kgh2o
571.4
553.1
0.32
85
775
(3020191) Ethanol [Moles/volume] in Serum or Plasma
5
35
1.43
0.39
1.4
1.4
promille
1.1
1.3
—
5
28
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
59
524
1.14
0.39
2.6
2.7
umol/l
12.3
8.0
0.37
51
454
(3029075) Extractable nuclear Ab panel - Serum
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
11
80
1.38
0.38
3.5
1.4
—
—
—
0
0
(3024731) MCV [Entitic volume]
552
5455
1.15
0.38
26.0
19.5
fl
90.7
90.9
0.47
542
5380
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
12
89
1.36
0.38
2.7
1.7
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
12
158
0.75
0.37
1.4
1.5
—
—
—
0
0
(3035941) MCH [Entitic mass]
552
5456
1.15
0.37
26.0
19.4
pg
30.2
30.3
0.34
542
5379
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
16
125
1.29
0.37
1.4
1.4
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
17
134
1.28
0.37
1.8
1.2
—
2.4
—
0
8
(3000093) Morphology [Interpretation] in Blood Narrative
5
37
1.35
0.37
1.0
1.1
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
552
5457
1.14
0.36
26.1
19.5
e12/l
4.5
4.5
0.05
539
5315
(3016650) Hepatitis A virus Ab [Presence] in Serum
11
81
1.36
0.36
1.1
1.1
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
552
5458
1.14
0.36
26.2
19.6
e9/l
6.9
6.6
1.81
540
5316
(3023410) Appearance of Cerebral spinal fluid
6
42
1.43
0.35
1.2
1.6
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
6
42
1.43
0.35
1.2
1.0
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
16
126
1.28
0.35
8.0
2.9
mg/l
1.6
1.5
0.36
16
114
(3030467) Casts [#/volume] in Urine by Automated count
136
1275
1.09
0.35
3.3
2.9
e6/l
0.5
0.4
0.02
112
949
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
177
1678
1.08
0.34
4.5
3.0
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
114
1061
1.09
0.34
5.5
3.7
kg/l
1.0
1.0
0.16
19
139
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
6
44
1.37
0.34
1.2
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
6
44
1.37
0.34
1.2
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
6
44
1.37
0.34
1.2
1.7
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
552
5460
1.14
0.34
26.2
19.6
g/l
135.5
135.7
0.15
542
5381
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
30
256
1.18
0.34
1.6
1.6
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
16
127
1.27
0.34
1.8
1.2
—
2.6
—
0
19
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
13
100
1.31
0.34
1.5
1.6
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
551
5453
1.13
0.31
26.2
19.5
e9/l
251.3
251.1
0.02
539
5321
(3014148) Varicella zoster virus Ab [Titer] in Serum
7
52
1.35
0.31
1.0
1.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
84
775
1.10
0.31
2.7
2.6
e6/l
1.7
1.0
0.89
58
436
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
7
53
1.32
0.31
6.0
2.7
u/ml
29.3
50.7
—
7
53
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
7
53
1.32
0.31
1.0
1.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
244
2349
1.07
0.30
6.1
4.8
estimate
0.0
0.0
0.00
59
445
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
10
75
1.34
0.30
1.6
1.5
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
7
55
1.28
0.30
1.3
1.1
—
—
—
0
0
(3000492) Spirometry study
53
478
1.12
0.30
1.6
1.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
105
1122
0.92
0.30
3.7
4.1
%
20.8
21.2
0.10
50
504
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
10
76
1.32
0.28
1.3
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
10
76
1.32
0.28
1.3
1.1
—
—
—
0
0
(3012501) Base excess in Blood by calculation
12
94
1.28
0.28
8.3
2.6
mmol/l
2.4
2.8
—
6
62
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
8
63
1.27
0.28
1.1
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
10
128
0.78
0.27
7.6
2.8
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
11
86
1.28
0.26
3.3
2.4
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
5
72
0.69
0.26
1.0
2.1
u/ml
2.8
60.4
—
5
67
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
27
235
1.16
0.25
11.0
9.4
—
—
—
0
0
(4306422)
9
72
1.25
0.25
1.1
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
23
198
1.17
0.25
2.6
1.7
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
6
85
0.70
0.24
1.0
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
6
85
0.70
0.24
1.0
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
23
199
1.16
0.24
1.2
1.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
23
199
1.16
0.24
2.3
1.8
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
23
199
1.16
0.24
2.3
1.8
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
38
1.32
0.23
1.0
1.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
26
295
0.88
0.23
1.9
1.8
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
23
200
1.16
0.22
2.3
1.8
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
16
189
0.84
0.22
2.0
3.4
u/ml
17.9
740.9
—
10
160
(3051611) Lipemic interference index of Serum or Plasma
5
40
1.25
0.22
3.8
3.5
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
10
79
1.27
0.22
1.5
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
41
1.22
0.22
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
41
1.22
0.22
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
41
1.22
0.22
1.2
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
55
508
1.09
0.21
2.3
1.9
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
42
1.19
0.21
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
42
1.19
0.21
1.2
1.1
—
—
—
0
0
(4062490)
5
42
1.19
0.21
1.0
1.3
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
42
1.19
0.21
1.2
1.1
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
0
12
0.00
0.21
0.0
1.1
—
0.8
—
0
5
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
15
126
1.20
0.21
1.3
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
5
43
1.16
0.21
1.4
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
6
48
1.25
0.20
1.0
1.6
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
14
0.00
0.20
0.0
1.9
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
9
113
0.79
0.20
1.1
1.8
—
—
—
0
0
(3008898) HLA-B27 [Presence]
17
197
0.86
0.20
1.1
1.1
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
6
50
1.20
0.19
2.0
1.2
—
—
—
0
0
(3044889) 12 lead EKG panel
329
3354
0.96
0.19
3.9
3.7
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
74
785
0.93
0.19
1.4
1.4
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
6
52
1.16
0.19
1.3
1.9
%
13.6
13.0
—
6
52
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
6
52
1.16
0.19
1.5
1.7
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
13
109
1.20
0.18
1.3
1.6
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
10
121
0.82
0.18
1.1
2.4
g/l
0.0
0.0
—
10
113
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
7
61
1.15
0.17
1.0
1.3
—
—
—
0
0
(40768793) Breast Pathology biopsy report
11
131
0.84
0.17
1.6
1.2
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
468
4630
1.05
0.17
4.6
3.9
mmol/l
1.4
1.3
2.37
430
4264
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
7
63
1.11
0.17
1.0
1.0
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
7
63
1.11
0.17
1.4
1.6
—
—
—
0
0
(4094501)
14
120
1.17
0.16
1.1
1.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
516
5119
1.06
0.16
17.6
12.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
78
0.77
0.15
1.0
1.5
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
69
726
0.94
0.15
3.0
2.7
e6/l
4.8
2.6
0.55
42
390
(3022621) pH of Urine by Test strip
28
306
0.91
0.15
4.5
2.5
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
9
83
1.09
0.14
5.8
2.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
124
1198
1.04
0.14
7.0
6.8
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
145
1407
1.04
0.14
3.8
3.0
e6/l
48.7
118.8
0.68
122
1077
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
46
489
0.94
0.13
3.0
4.2
ug/l
3.7
22.2
1.16
37
407
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
9
106
0.85
0.13
1.3
1.6
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
128
1319
0.96
0.12
4.4
3.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
242
2378
1.03
0.11
4.9
3.5
estimate
0.0
0.0
0.80
55
428
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
59
563
1.05
0.11
2.2
2.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
13
115
1.13
0.10
5.5
1.8
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
5
47
1.06
0.09
1.0
1.3
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
5
48
1.04
0.09
2.0
1.3
ug/l
4.1
2.9
—
5
41
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
6
55
1.09
0.09
2.5
4.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
6
56
1.07
0.08
1.0
1.3
nmol/l
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
6
56
1.07
0.08
1.0
1.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
62
0.80
0.08
1.0
1.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
20
185
1.08
0.08
2.4
1.8
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
7
64
1.09
0.08
1.0
1.3
nmol/l
0.6
0.5
—
7
59
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
11
123
0.89
0.08
1.1
2.4
g/l
0.0
0.0
0.00
11
114
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
7
80
0.87
0.07
1.0
1.1
—
14.1
—
0
6
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
19
204
0.93
0.07
1.6
1.5
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
12
132
0.91
0.06
1.1
2.4
g/l
0.0
0.0
0.50
12
123
(3000330) Specific gravity of Urine by Test strip
25
236
1.06
0.06
4.4
3.4
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
11
99
1.11
0.06
2.0
2.9
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
13
142
0.91
0.06
1.0
1.1
—
5.9
—
0
19
(4034850)
16
148
1.08
0.06
7.6
9.0
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
125
1272
0.98
0.06
1.7
1.7
mmol/l
1.5
1.4
0.85
106
1069
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
95
932
1.02
0.05
1.6
1.5
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
168
1660
1.02
0.05
4.1
3.5
e6/l
86.3
95.1
0.09
136
1169
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
18
191
0.94
0.04
2.5
1.9
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
27
260
1.04
0.03
1.1
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
45
439
1.03
0.03
2.0
1.7
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
140
1387
1.01
0.02
4.8
4.5
ug/l
1.9
2.8
0.97
130
1249
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
28
271
1.03
0.02
4.0
2.9
u/ml
40.4
63.6
0.40
28
263
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
15
142
1.06
0.02
1.7
1.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
31
301
1.03
0.02
1.2
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
24
248
0.97
0.02
1.5
1.8
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
15
157
0.95
0.01
2.9
1.8
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
126
1251
1.01
0.01
3.4
2.9
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
15
144
1.04
0.00
1.3
1.5
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
12
125
0.96
0.00
1.3
1.1
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
10
97
1.03
0.00
1.7
2.0
pmol/l
175.1
227.1
—
10
89
(3014051) Protein [Presence] in Urine by Test strip
11
107
1.03
0.00
3.5
2.0
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
10
102
0.98
0.00
1.0
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
13
128
1.02
0.00
5.1
4.4
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
15
152
0.99
0.00
1.1
1.3
miu/ml
140.4
244.6
—
5
76
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
16
158
1.01
0.00
1.5
1.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
17
172
0.99
0.00
3.0
2.5
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
23
228
1.01
0.00
1.8
1.8
—
—
—
0
0
(3002256) Pathology report gross observation
60
598
1.00
0.00
1.3
1.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
88
878
1.00
0.00
2.3
1.8
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
35
351
1.00
0.00
1.6
1.4
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
213
2135
1.00
0.00
11.4
9.1
e9/l
0.0
0.0
0.26
177
1769
(3013466) aPTT in Blood by Coagulation assay
0
5
0.00
0.00
0.0
1.0
—
34.3
—
0
5
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
8.6
—
0.5
—
0
5
(3032700) Glomerular basement membrane Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3023436) Glucagon [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
190.4
—
0
5
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(4281824)
5
51
0.98
0.00
1.0
1.1
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
7
76
0.92
0.00
1.0
1.7
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.3
—
1.9
—
0
6
(3042111) Morphology [Interpretation] in Bone marrow Narrative
7
72
0.97
0.00
1.3
1.7
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
5
58
0.86
0.00
2.2
1.8
—
—
—
0
0
(4268621)
5
51
0.98
0.00
2.0
2.4
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
6
61
0.98
0.00
3.7
2.8
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
7
76
0.92
0.00
2.0
1.3
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
6
0.00
0.00
0.0
2.5
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
40.2
—
0
6
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
9
95
0.95
0.00
1.4
1.4
—
—
—
0
0
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
0
6
0.00
0.00
0.0
1.0
—
119.0
—
0
6
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
6
0.00
0.00
0.0
3.8
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
5
51
0.98
0.00
1.4
1.1
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint H8_EXT_NONINF and mortality.

Females

Parameter HR [95% CI] p-value
H8_EXT_NONINF 1.437 [1.24, 1.66] < 0.001
Birth year 0.992 [0.98, 1.0] 0.076

During the follow-up period (1.1.1998 — 31.12.2019), 358 out of 2245 females with H8_EXT_NONINF died.

Males

Parameter HR [95% CI] p-value
H8_EXT_NONINF 1.369 [1.2, 1.56] < 0.001
Birth year 0.99 [0.98, 1.0] 0.029

During the follow-up period (1.1.1998 — 31.12.2019), 486 out of 2048 males with H8_EXT_NONINF died.

Mortality risk

Mortality risk for people of age

years, who have H8_EXT_NONINF.

N-year risk Females Males
1 0.152% 0.252%
5 0.83% 1.636%
10 2.1% 4.116%
15 3.908% 7.577%
20 6.395% 13.316%

Relationships between endpoints

Index endpoint: H8_EXT_NONINF – Acute otitis externa, noninfective

GWS hits: 2

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data